more emphasis on promoting adherence with Pradaxa (dabigatran), Xarelto (rivaroxaban), and Eliquis (apixaban)

You'll see more emphasis on promoting adherence with Pradaxa (dabigatran), Xarelto (rivaroxaban), and Eliquis (apixaban).

The concern is that stopping one of these "anticoagulant" blood thinners...even for a few days...can quickly return patients to their risk of stroke before starting therapy.

Help ensure your patients are taking their anticoagulants.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote